We invite you to learn more about:
- New and emerging therapies for myeloma
- What to do when myeloma relapses
- CAR T-cell therapy for myeloma
- The importance of discussing quality-of-life issues with your treatment team
Noa Biran, MDAssistant Professor of MedicineJohn Theurer Cancer CenterMultiple Myeloma DivisionHackensack Meridian HealthHackensack, NJ
Transcript will be available soon.
Support for this program is provided by Bristol Myers Squibb, Genentech and Biogen, GlaxoSmithKline, Janssen Biotech, and Oncopeptides.